Zimmer Biomet
739 hedge funds and large institutions have $25.3B invested in Zimmer Biomet in 2015 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 219 increasing their positions, 276 reducing their positions, and 63 closing their positions.
44% more funds holding in top 10
Funds holding in top 10: 9 → 13 (+4)
38% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 63
9% more capital invested
Capital invested by funds: $23.1B → $25.3B (+$2.18B)
2% more funds holding
Funds holding: 725 → 739 (+14)
0.09% more ownership
Funds ownership: 125.65% → 125.75% (+0.09%)
21% less repeat investments, than reductions
Existing positions increased: 219 | Existing positions reduced: 276
50% less call options, than puts
Call options by funds: $23.2M | Put options by funds: $46M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$559M |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$356M |
| 3 |
HM
HealthCor Management
New York
|
+$90.7M |
| 4 |
D.E. Shaw & Co
New York
|
+$82.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$55.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$364M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$323M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$200M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$91.8M |
| 5 |
Two Sigma Advisers
New York
|
-$64.1M |
ZBH Hedge Fund Activity: Q4 2015 in Review
739 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2015, worth a combined $25.3B — up 9.4% from $23.1B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new ZBH positions and 63 closed out — a net gain of 24 holders — while 219 added to existing stakes and 276 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $559M. The largest seller was Fidelity Investments, cutting an estimated $364M.
- 739 institutional investors held Zimmer Biomet (ZBH) as of Q4 2015, up from 725 in Q3 2015.
- Funds reported $25.3B of Zimmer Biomet stock for Q4 2015, up 9.4% quarter-over-quarter.
- 87 funds opened new Zimmer Biomet positions in Q4 2015 and 63 closed out, a net change of +24 holders.
- The largest Zimmer Biomet buyer in Q4 2015 was Massachusetts Financial Services, an estimated $559M added.
- The largest Zimmer Biomet seller in Q4 2015 was Fidelity Investments, an estimated $364M sold.
Based on aggregated 13F filings for Q4 2015.